Effects of statin treatment in men and women with stable coronary heart disease: a subgroup analysis of the GREACE Study

References

• Barrett-Connor E. Sex differences in coronary heart disease. Why are women so superior? The 1995 Ancel Keys Lecture. Circulation 1997;95: 252–64
   PubMed Web of Science ®Google Scholar
• Bairey Merz CN, Olson MB, Johnson BD, . Cholesterol-lowering medication, cholesterol level, and reproductive hormones in women: The Women's Ischemia Syndrome Evaluation (WISE). Am J Med 2002;113: 723–7
   PubMed Web of Science ®Google Scholar
• The National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285: 2486–97
   PubMed Web of Science ®Google Scholar
• Ding EL, Powe NR, Manson JE, . Sex differences in perceived risks, distrust, and willingness to participate in clinical trials. A randomized study of cardiovascular prevention trials. Arch Intern Med 2007;167: 905–12
   PubMed Web of Science ®Google Scholar
• Blomkalns AL, Chen AY, Hochman JS, . Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines) National Quality Improvement Initiative. J Am Coll Cardiol 2005;45: 832–7
   PubMed Web of Science ®Google Scholar
• Athyros VG, Papageorgiou AA, Mercouris BR, . Treatment with atorvastatin to the National Cholesterol Educational Program goals versus usual care in secondary Coronary Heart Disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study. Curr Med Res Opin 2002;18: 220–8
   PubMed Web of Science ®Google Scholar
• Athyros VG, Mikhailidis DP, Papageorgiou AA, . The effect of statins versus untreated dyslipidemia on renal function in patients with coronary heart disease: a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) study. J Clin Pathol 2004;57: 728–34
   PubMed Web of Science ®Google Scholar
• Athyros VG, Elisaf M, Papageorgiou AA, . GREACE Study Collaborative Group. Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) study. Am J Kidney Dis 2004;43: 589–99
   PubMed Web of Science ®Google Scholar
• Athyros VG, Mikhailidis DP, Liberopoulos EN, . Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: A subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) study. Nephrol Dial Transplant 2007;22: 118–27
   PubMed Web of Science ®Google Scholar
• Liberopoulos EN, Mikhailidis DP, Athyros VG, Elisaf MS. The effect of cholesterol lowering treatment on renal function. Am J Kidney Dis 2006;47: 561
   PubMed Web of Science ®Google Scholar
• Levey AS, Bosch JP, Lewis JB, . A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999;130: 461–70
   PubMed Web of Science ®Google Scholar
• Kaplan RC, Heckbert SR, Furberg CD, Psaty BM. Predictors of subsequent coronary events, stroke, and death among survivors of first hospitalized myocardial infarction. J Clin Epidemiol 2002;55: 654–64
   PubMed Web of Science ®Google Scholar
• Lewis SJ, Sacks FM, Jayne S. Mitchell JS, . Effect of pravastatin on cardiovascular events in women after myocardial infarction: the Cholesterol and Recurrent Events (CARE) trial. J Am Col Cardiol 1998;32: 140–6
   PubMed Web of Science ®Google Scholar
• Miettinen TA, Pyorala K, Olsson AG, . Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris. Circulation 1997;96: 4211–18
   PubMed Web of Science ®Google Scholar
• Wenger NK, Lewis SJ, Welty FK, . Beneficial effects of aggressive LDL cholesterol lowering in women with stable coronary heart disease in the Treating to New Targets (TNT) study. Heart 2008;94: 434–9. Epub 2007 10 Dec. PMID 18070940
   PubMed Web of Science ®Google Scholar
• Athyros VG, Mikhailidis DP, Papageorgiou AA, . GREACE Collaborative Group. Effect of atorvastatin on high density lipoprotein cholesterol and its relationship with coronary events: a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) study. Curr Med Res Opin 2004;20: 627–37
   PubMed Web of Science ®Google Scholar
• Branchi A, Fiorenza AM, Torri A, . Atorvastatin increases HDL cholesterol in hypercholesterolemic patients. Evidence of a relationship with baseline HDL cholesterol. Nutr Metab Cardiovasc Dis 2002;12: 24–8
   PubMed Web of Science ®Google Scholar
• Athyros VG, Mikhailidis DP, Kakafika AI, . Identifying and attaining LDL-C goals: mission accomplished? Next target: new therapeutic options to raise HDL-C levels. Curr Drug Targets 2007;8: 483–8
   PubMed Web of Science ®Google Scholar
• Athyros VG, Kakafika AI, Tziomalos K, . Cholesteryl ester transfer protein inhibition and HDL increase: has the dream ended?. Exp Opin Invest Drugs 2008(in press)
   Web of Science ®Google Scholar
• Athyros VG, Kakafika AI, Papageorgiou AA, . Statin-induced increase in HDL-C and renal function in coronary heart disease patients. Open Cardiovasc Med J 2007;1: 8–14
   PubMedGoogle Scholar
• Abrass CK. Cellular lipid metabolism and the role of lipids in progressive renal disease. Am J Nephrol 2004;24: 46–53
   PubMed Web of Science ®Google Scholar
• Sprecher DL, Pearce GL, Cosgrove DM, . Relation of serum triglyceride levels to survival after coronary artery bypass grafting. Am J Cardiol 2000;86: 285–8
   PubMed Web of Science ®Google Scholar
• Athyros VG, Kakafika AI, Papageorgiou AA, . GREACE Study Collaborative Group. Atorvastatin decreases triacylglycerol-associated risk of vascular events in coronary heart disease patients. Lipids 2007;42: 999–1009
   Google Scholar
• Lee WL, Cheung AM, Cape A, Zinman B. Impact of diabetes on coronary artery disease in women and men. A meta-analysis of prospective studies. Diabetes Care 2000;23: 962–8
   PubMed Web of Science ®Google Scholar
• Athyros VG, Papageorgiou AA, Symeonidis AN, . GREACE Study Collaborative Group. Early benefit from structured care with atorvastatin in patients with coronary heart disease and diabetes mellitus. Angiology 2003;54: 679–90
   Google Scholar
• Athyros VG, Papageorgiou AA, Athyrou VV, . Atorvastatin and micronized fenofibrate alone and in combination in type 2 diabetes with combined hyperlipidemia. Diabetes Care 2002;25: 1198–202
   PubMed Web of Science ®Google Scholar